Arena Pharmaceuticals Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 9.8 | 19.3 | 30.6 |
| Cost of Goods Sold | 8.5 | -- | -- |
| Gross Profit | 1.3 | -- | -- |
| Gross Profit Margin | 13.2% | 0.0% | 0.0% |
| SG&A Expense | 30.5 | 26.6 | 18.5 |
| Depreciation & Amortization | 2.3 | 1.5 | 1.5 |
| Operating Income | -- | -- | -- |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | (3.3) | 0.0 | 0.3 |
| Nonoperating Expenses | 1.7 | -- | -- |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | (237.6) | (145.3) | (88.3) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (237.6) | (145.3) | (88.3) |
| Total Net Income | (237.6) | (145.3) | (88.3) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (3.24) | (2.31) | (1.89) |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
